• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣植入术:应对永久起搏器植入的后续风险

Transcatheter Aortic Valve Implantation: Addressing the Subsequent Risk of Permanent Pacemaker Implantation.

作者信息

Lauten Philipp, Costello-Boerrigter Lisa C, Goebel Björn, Gonzalez-Lopez David, Schreiber Matthias, Kuntze Thomas, Al Jassem Mahmoud, Lapp Harald

机构信息

Department of Cardiology, Heart Center, Zentralklinik Bad Berka, Robert-Koch-Allee 9, 99437 Bad Berka, Germany.

出版信息

J Cardiovasc Dev Dis. 2023 May 24;10(6):230. doi: 10.3390/jcdd10060230.

DOI:10.3390/jcdd10060230
PMID:37367395
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10299451/
Abstract

Transcatheter aortic valve implantation (TAVI) is now a commonly used therapy in patients with severe aortic stenosis, even in those patients at low surgical risk. The indications for TAVI have broadened as the therapy has proven to be safe and effective. Most challenges associated with TAVI after its initial introduction have been impressively reduced; however, the possible need for post-TAVI permanent pacemaker implantation (PPI) secondary to conduction disturbances continues to be on the radar. Conduction abnormalities post-TAVI are always of concern given that the aortic valve lies in close proximity to critical components of the cardiac conduction system. This review will present a summary of noteworthy pre-and post-procedural conduction blocks, the best use of telemetry and ambulatory device monitoring to avoid unnecessary PPI or to recognize the need for late PPI due to delayed high-grade conduction blocks, predictors to identify those patients at greatest risk of requiring PPI, important CT measurements and considerations to optimize TAVI planning, and the utility of the MInimizing Depth According to the membranous Septum (MIDAS) technique and the cusp-overlap technique. It is stressed that careful membranous septal (MS) length measurement by MDCT during pre-TAVI planning is necessary to establish the optimal implantation depth before the procedure to reduce the risk of compression of the MS and consequent damage to the cardiac conduction system.

摘要

经导管主动脉瓣植入术(TAVI)现已成为重度主动脉瓣狭窄患者常用的治疗方法,即使是手术风险较低的患者。随着该治疗方法被证明安全有效,TAVI的适应证不断扩大。TAVI最初应用后所面临的大多数挑战已显著减少;然而,TAVI术后因传导障碍可能需要植入永久性起搏器(PPI)这一问题仍备受关注。鉴于主动脉瓣紧邻心脏传导系统的关键组成部分,TAVI术后的传导异常一直令人担忧。本综述将总结术前和术后值得关注的传导阻滞情况、遥测和动态设备监测的最佳应用,以避免不必要的PPI或识别因延迟的高度传导阻滞而需要晚期PPI的情况、识别那些最有可能需要PPI的患者的预测因素、优化TAVI规划的重要CT测量和注意事项,以及根据膜周部间隔最小化深度(MIDAS)技术和瓣叶重叠技术的效用。强调在TAVI术前规划期间通过MDCT仔细测量膜周部间隔(MS)长度对于在手术前确定最佳植入深度以降低MS受压及随后心脏传导系统受损风险是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6564/10299451/2dbea5bdb69e/jcdd-10-00230-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6564/10299451/c6d4db6a42a4/jcdd-10-00230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6564/10299451/f054dd048473/jcdd-10-00230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6564/10299451/911d262a67f5/jcdd-10-00230-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6564/10299451/2dbea5bdb69e/jcdd-10-00230-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6564/10299451/c6d4db6a42a4/jcdd-10-00230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6564/10299451/f054dd048473/jcdd-10-00230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6564/10299451/911d262a67f5/jcdd-10-00230-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6564/10299451/2dbea5bdb69e/jcdd-10-00230-g004.jpg

相似文献

1
Transcatheter Aortic Valve Implantation: Addressing the Subsequent Risk of Permanent Pacemaker Implantation.经导管主动脉瓣植入术:应对永久起搏器植入的后续风险
J Cardiovasc Dev Dis. 2023 May 24;10(6):230. doi: 10.3390/jcdd10060230.
2
Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.经导管植入 CoreValve 主动脉生物瓣后的传导障碍和永久性心脏起搏:初始单中心经验。
Kardiol Pol. 2012;70(2):121-8.
3
Computed tomography-derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta-analysis of observational studies.基于 CT 的室间隔膜部长度预测 TAVI 术后传导异常和永久性起搏器植入的价值:一项观察性研究的荟萃分析。
Catheter Cardiovasc Interv. 2023 Jun;101(7):1203-1213. doi: 10.1002/ccd.30666. Epub 2023 Apr 18.
4
Depth of implantation in relation to membranous septum as a predictor of conduction disturbances after transcatheter aortic valve implantation.经导管主动脉瓣植入术后,植入深度与膜性间隔的关系作为传导障碍的预测指标
Indian Pacing Electrophysiol J. 2024 May-Jun;24(3):133-139. doi: 10.1016/j.ipej.2024.03.003. Epub 2024 Mar 26.
5
Inverse Relationship Between Membranous Septal Length and the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation.经导管主动脉瓣置换术患者中膜性间隔长度与房室传导阻滞风险的反比关系。
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1218-1228. doi: 10.1016/j.jcin.2015.05.010.
6
Anatomical Annulus Predictors of New Permanent Pacemaker Implantation Risk After Balloon-Expandable Transcatheter Aortic Valve Implantation.球囊扩张式经导管主动脉瓣植入术后新永久性起搏器植入风险的解剖学瓣环预测因素
Am J Cardiol. 2024 Aug 1;224:26-35. doi: 10.1016/j.amjcard.2024.05.034. Epub 2024 Jun 4.
7
Incidence, predictors, and clinical outcomes of permanent pacemaker insertion following transcatheter aortic valve implantation in an Arab population.在阿拉伯人群中,经导管主动脉瓣植入术后永久性心脏起搏器植入的发生率、预测因素和临床转归。
J Interv Card Electrophysiol. 2022 Apr;63(3):545-554. doi: 10.1007/s10840-021-01039-2. Epub 2021 Aug 24.
8
Severe conduction defects requiring permanent pacemaker implantation in patients with a new-onset left bundle branch block after transcatheter aortic valve implantation.经导管主动脉瓣植入术后新发左束支传导阻滞患者中需要永久性起搏器植入的严重传导缺陷。
Europace. 2017 Jun 1;19(6):1015-1021. doi: 10.1093/europace/euw174.
9
Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review.经导管主动脉瓣置换术后早期和新一代器械植入起搏器的比率:系统评价。
Eur Heart J. 2018 Jun 1;39(21):2003-2013. doi: 10.1093/eurheartj/ehx785.
10
Risk Assessment of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation in Patients With Preexisting Right Bundle Branch Block.经导管主动脉瓣置换术后伴有预存右束支传导阻滞患者行永久起搏器植入的风险评估。
Am J Cardiol. 2024 Feb 15;213:151-160. doi: 10.1016/j.amjcard.2023.12.004. Epub 2023 Dec 15.

引用本文的文献

1
Individualized Selection of Valve Intervention Strategies in Aortic Disease Is Key for Better Outcomes.主动脉疾病中瓣膜干预策略的个体化选择是取得更好治疗效果的关键。
J Pers Med. 2025 Aug 1;15(8):337. doi: 10.3390/jpm15080337.
2
A Two-Step Risk Score for Prediction of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后永久性起搏器植入预测的两步风险评分
J Am Heart Assoc. 2025 May 20;14(10):e039036. doi: 10.1161/JAHA.124.039036. Epub 2025 May 15.
3
[Left bundle branch pacing in a patient with decreased cardiac function after transcatheter aortic valve replacement].

本文引用的文献

1
A 20-year journey in transcatheter aortic valve implantation: Evolution to current eminence.经导管主动脉瓣植入20年历程:发展至当前的卓越地位。
Front Cardiovasc Med. 2022 Nov 21;9:971762. doi: 10.3389/fcvm.2022.971762. eCollection 2022.
2
Sex difference and outcome trends following transcatheter aortic valve replacement.经导管主动脉瓣置换术后的性别差异及预后趋势
Front Cardiovasc Med. 2022 Oct 18;9:1013739. doi: 10.3389/fcvm.2022.1013739. eCollection 2022.
3
Permanent pacemaker implantation and left bundle branch block with self-expanding valves - a SCOPE 2 subanalysis.
[经导管主动脉瓣置换术后心功能减退患者的左束支起搏]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Mar 25;54(2):149-153. doi: 10.3724/zdxbyxb-2024-0359.
4
Early clinical outcomes of transcatheter aortic valve implantation using the NAVITOR system.使用NAVITOR系统进行经导管主动脉瓣植入术的早期临床结果。
Cardiovasc Interv Ther. 2025 Apr;40(2):378-388. doi: 10.1007/s12928-024-01081-7. Epub 2025 Jan 6.
5
Conduction Abnormalities after Transcatheter Aortic Valve Implantation: Incidence, Impact and Management Using CT Data Interpretation.经导管主动脉瓣植入术后的传导异常:基于CT数据解读的发生率、影响及处理
Interv Cardiol. 2024 Aug 13;19:e12. doi: 10.15420/icr.2024.11. eCollection 2024.
6
Risk of permanent pacemaker implantation following transcatheter aortic valve replacement: Which factors are most relevant?经导管主动脉瓣置换术后永久性起搏器植入的风险:哪些因素最为相关?
World J Cardiol. 2024 Feb 26;16(2):49-53. doi: 10.4330/wjc.v16.i2.49.
永久心脏起搏器植入术与自膨式瓣膜伴左束支传导阻滞:SCOPE 2 子分析。
EuroIntervention. 2023 Feb 6;18(13):e1077-e1087. doi: 10.4244/EIJ-D-22-00558.
4
The application of 3D printing in preoperative planning for transcatheter aortic valve replacement: a systematic review.3D 打印在经导管主动脉瓣置换术术前规划中的应用:系统评价。
Biomed Eng Online. 2022 Sep 1;21(1):59. doi: 10.1186/s12938-022-01029-z.
5
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and balloon-expandable valves: a post hoc analysis from the SOLVE-TAVI trial.经导管主动脉瓣置换术治疗严重主动脉瓣狭窄患者中,中重度左心室流出道钙化对自膨式和球囊扩张式瓣膜的临床结局的影响:来自 SOLVE-TAVI 试验的事后分析。
EuroIntervention. 2022 Oct 21;18(9):759-768. doi: 10.4244/EIJ-D-22-00156.
6
Preoperative TAVR Planning: How to Do It.术前经导管主动脉瓣置换术(TAVR)规划:如何进行
J Clin Med. 2022 May 5;11(9):2582. doi: 10.3390/jcm11092582.
7
Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation.经导管主动脉瓣置入术治疗人工瓣膜衰败的疗效
Am J Cardiol. 2022 Jun 1;172:81-89. doi: 10.1016/j.amjcard.2022.02.028. Epub 2022 Mar 26.
8
Transcatheter Aortic Valve Replacement with the Self-Expandable Core Valve Evolut Prosthesis Using the Cusp-Overlap vs. Tricusp-View.使用瓣叶重叠法与三尖瓣视图,采用自膨胀式CoreValve Evolut人工瓣膜进行经导管主动脉瓣置换术
J Clin Med. 2022 Mar 12;11(6):1561. doi: 10.3390/jcm11061561.
9
The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients.PARTNER 3 二叶式主动脉瓣经导管主动脉瓣置换术在低手术风险患者中的登记研究。
JACC Cardiovasc Interv. 2022 Mar 14;15(5):523-532. doi: 10.1016/j.jcin.2022.01.279.
10
Incidence and Predictors of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Procedures: Data of The Netherlands Heart Registration (NHR).经导管主动脉瓣手术后永久性起搏器植入的发生率及预测因素:荷兰心脏注册研究(NHR)数据
J Clin Med. 2022 Jan 23;11(3):560. doi: 10.3390/jcm11030560.